Square, Beximco get US approval - Share market analysis of dhaka stock exchange, Bangladesh

Send This Page To Friends and Colleagues

You can Enter more than one email separated by (,)
Allowed 100 characters only
24 June, 2015 09:58 AM Source: The Daily Star Bangladesh

The US Food and Drug Administration or FDA has recently given its approval to Square Pharmaceuticals and Beximco Pharmaceuticals after inspecting the oral solid dosage facilities of the two companies in Bangladesh.

On June 16, the FDA released its Establishment Inspection Report under which it was audited whether the firms are following the current good manufacturing practices.

The approval is given based on the comprehensive audit on all the systems of drug manufacturing: quality, facilities and equipment, materials, production, packaging and labelling and laboratory controls, according to the statements issued by the two Bangladeshi firms.

The inspections ended without issuing any 483 form. A 483 form is issued when the FDA has observations of non-compliance or deviation from good manufacturing practices.

"This is a remarkable achievement for Bangladesh's pharmaceutical industry as this makes ways for us to export medicines to the US market known for stringent regulations and quality standards," said Nazmul Hassan, managing director of Beximco Pharma.

Add Comment | 0   comment

Readers Comment

Nothing found to display
page number 1

Add Comment

Please login first to comment Click here to login
Advanced Charts
Market Map
Real-Time Market Watch
Order Book Data
Stock Screener
LankaBangla Client Login
CSE iTrading
Trading Game
DSE iTrading

Stocks in Focus

Features for Registered Users

E-mail Alerts
Daily Newsletter
Your Watchlist
Advanced Tools
Many more

Will automatically display the last quotes you have visited here.

All Rights Reserved - DUInvest © 2013


Do You have an Account ? , Click here to create a new account

Your Opinion Matters

What do you think about the new Website?